Is ANGN or NOBL a better dividend investment in 2026?

ANGN currently yields 200.00% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: ANGN offers higher current income.

What is the dividend yield difference between ANGN and NOBL?

ANGN has a forward dividend yield of 200.00% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 196.00 percentage points.

Home › Compare › ANGN vs NOBL

ANGN vs NOBL: Dividend Comparison 2026

ANGN yields 200.00% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ANGN wins by $119.34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ANGN

● Live price

200.00%

Share price

$1.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$119.36M

Annual income

$60,176,096.29

Full ANGN calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — ANGN vs NOBL

📍 ANGN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ANGN	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ANGN + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ANGN pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ANGN

Annual income on $10K today (after 15% tax)

$17,000.00/yr

After 10yr DRIP, annual income (after tax)

$51,149,681.85/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, ANGN beats the other by $51,148,917.54/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ANGN + NOBL for your $10,000?

ANGN: 50%NOBL: 50%

100% NOBL50/50100% ANGN

Portfolio after 10yr

$59.70M

Annual income

$30,088,497.74/yr

Blended yield

50.40%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ANGN right now

ANGN

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$1.50

+50.0% upside vs current

Range: $1.50 — $1.50

Altman Z

-16.3

Piotroski

3/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ANGN buys

NOBL buys

No recent congressional trades found for ANGN or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricANGNNOBL

Forward yield	200.00% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$119.36M ✓	$28.0K
Annual income after 10y	$60,176,096.29 ✓	$899.19
Total dividends collected	$112.49M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ANGN vs NOBL ($10,000, DRIP)

Year	ANGN Portfolio	ANGN Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$30,700	$20,000.00	$11,120	$420.00	+$19.6K → ANGN
2	$90,232	$57,383.18	$12,357	$458.31	+$77.9K → ANGN
3	$254,173	$157,624.56	$13,721	$499.76	+$240.5K → ANGN
4	$686,927	$414,961.74	$15,227	$544.58	+$671.7K → ANGN
5	$1,783,118	$1,048,106.39	$16,885	$593.02	+$1.77M → ANGN
6	$4,450,613	$2,542,677.12	$18,713	$645.34	+$4.43M → ANGN
7	$10,693,420	$5,931,263.38	$20,724	$701.81	+$10.67M → ANGN
8	$24,760,608	$13,318,648.86	$22,938	$762.73	+$24.74M → ANGN
9	$55,315,649	$28,821,798.66	$25,372	$828.41	+$55.29M → ANGN
10	$119,363,841	$60,176,096.29	$28,047	$899.19	+$119.34M → ANGN

ANGN vs NOBL: Complete Analysis 2026

ANGN — Stock

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.

Full ANGN Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this ANGN vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ANGN vs SCHD ANGN vs JEPI ANGN vs O ANGN vs KO ANGN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.